← Back to Search

Behavioral Intervention

ENTRUST Program for Substance Use Disorder and HIV/AIDS (ENTRUST Trial)

N/A
Waitlist Available
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to study the effectiveness of a program called ENTRUST in helping transgender women in Florida who are at high risk for substance use disorders and HIV. ENTRUST provides financial education and counseling

Who is the study for?
This trial is for adult transgender women in South or Central Florida who are economically disadvantaged and at high risk for substance use disorders and HIV. They must be willing to engage in substance use services, HIV care, or PrEP programs, and able to attend study visits either remotely or in person.
What is being tested?
The ENTRUST intervention combines financial education with tailored counseling (SBIRT) aimed at helping participants manage substance use and access HIV services. Participants will either receive this new approach immediately or after a waitlist period, during which they can still complete study visits.
What are the potential side effects?
Since the interventions involve counseling and education rather than medical treatments, traditional side effects are not expected. However, discussing sensitive topics may cause emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of people engaging and being retained in substance use and HIV services
Number of people linking to other support services other than substance use or HIV services
Secondary study objectives
HIV diagnosis
Substance Use Disorder Diagnosis

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
ENTRUST intervention comprised of adapted SBIRT-T, economic strengthening and photovoice training
Group II: Waitlist ControlActive Control1 Intervention
SBIRT-T only

Find a Location

Who is running the clinical trial?

University of Central FloridaLead Sponsor
92 Previous Clinical Trials
1,120,156 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,594 Previous Clinical Trials
3,328,616 Total Patients Enrolled
~80 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top